Abstract
Active surveillance is a management plan for localized prostate cancer that offers selective delayed intervention on indication of disease progression, allowing patients to delay or avoid treatment and associated side-effects. Outcomes from centers that promote active surveillance are favorable, with high rates of disease-specific survival. However, there remains a need for prognostic variables or biomarkers that distinguish with high specificity the aggressive cancers that progress on surveillance from the indolent cancers. The Canary Prostate Active Surveillance Study is a multicenter study and a biorepository that will discover and confirm biomarkers of aggressive disease as defined by histologic, prostate-specific antigen, or clinical criteria.
Original language | English (US) |
---|---|
Pages (from-to) | 407-413 |
Number of pages | 7 |
Journal | Urology |
Volume | 75 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2010 |
Externally published | Yes |
ASJC Scopus subject areas
- Urology